1737 North First Street Suite 290 San Jose CA 95112
hepatitis drug;
Where the owner name is not linked, that owner no longer owns the brand
Technical Examples
A method and pharmaceutical combination for treating hepatitis C by administering to a hepatitis C patient an effective amount of at least one alpha thymosin peptide, in combination with administration to the hepatitis C patient of an effective amount of at least one interferon, and optionally in combination with administration of at least one antiviral agent such as ribavirin.